-
State regulators voted against a proposed deal to sell Aquarion to the New Haven-based Regional Water Authority for $2.4 billion.
-
The state of Connecticut will get $64 million from Purdue Pharma and the Sackler family for their role in the opioid crisis. It's part of a $7.4 billion settlement announced by the U.S. Bankruptcy Court for the Southern District of New York.
-
A tiny forest creature has taken Connecticut by storm. Labubu collectibles, once a niche designer toy, are now the must-have holiday craze, drawing in Gen Z, college students and seasoned collectors as prices soar and shelves empty.
-
Winter is coming, and advocates fear that the Trump administration's cuts could force thousands more Connecticut residents into homelessness as federal housing aid is slashed by 70%.
-
Connecticut lawmakers have approved UConn Health’s purchase of three troubled hospitals in the state.
-
The Nassau County executive is trying to convince Republicans to support him instead of Rep. Elise Stefanik, who recently announced a gubernatorial bid.
-
In his social media launch video, Connecticut Gov. Ned Lamont pitched himself as an experienced leader focused on education, fiscal responsibility and health care.
-
Connecticut Senate Democrats approved using $500 million of state surplus money to backstop federal cuts to safety net programs in a special session on Thursday.
-
The state on Wednesday agreed to delay the implementation of the All-Electric Building Act, which was set to go into effect in January.
-
Around 5 p.m. on Wednesday, the main barn at Wells Farm caught fire and burned down. While the barn next to it also caught fire, the structure of it was maintained.
-
Early Start CT was launched by Gov. Ned Lamont’s (D) administration this summer. It aims to subsidize pre-K for families who might otherwise be unable to send their children.
-
Nationwide, the rules on COVID shots are uneven: the supply of COVID-19 vaccines remains steady, but access is confusing. Federal guidance from the Centers for Disease Control and Prevention (CDC) now primarily flags vaccines for adults 65 and older or those with certain health conditions.